Detalhe da pesquisa
1.
Changes in Metabolomic Profiles Induced by Switching from an Erythropoiesis-Stimulating Agent to a Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor in Hemodialysis Patients: A Pilot Study.
Int J Mol Sci
; 24(16)2023 Aug 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37628932